Clinic Roundup
Mesoblast Ltd., of Melbourne, Australia, reported that the first lumbar disc procedure was successfully performed in the Phase II trial of its adult mesenchymal precursor cell (MPC) product.
To continue reading subscribe now to BioWorld Today
Learn More about BioWorld Today
Already a subscriber? Sign In or Buy now to activate your subscription
Note: our contact information has changed
Customer Care: http://support.clarivate.com
© 2018 Clarivate Analytics.
Reproduction, reposting content is strictly prohibited.
Reproduction, reposting content is strictly prohibited.